183 related articles for article (PubMed ID: 33284486)
21. The Pharmaceutical Device Prisma
Belvedere R; Bizzarro V; Parente L; Petrella F; Petrella A
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757565
[TBL] [Abstract][Full Text] [Related]
22. Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activity.
Dai H; Yu Z; Fan X; Liu N; Yan M; Chen Z; Lo EH; Hajjar KA; Wang X
Thromb Haemost; 2013 Jun; 109(6):1070-8. PubMed ID: 23572070
[TBL] [Abstract][Full Text] [Related]
23. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
Sharma MC; Sharma M
Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
[TBL] [Abstract][Full Text] [Related]
24. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
[TBL] [Abstract][Full Text] [Related]
25. Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2.
Peterson EA; Sutherland MR; Nesheim ME; Pryzdial EL
J Cell Sci; 2003 Jun; 116(Pt 12):2399-408. PubMed ID: 12724354
[TBL] [Abstract][Full Text] [Related]
26. Mesoglycan induces the secretion of microvesicles by keratinocytes able to activate human fibroblasts and endothelial cells: A novel mechanism in skin wound healing.
Belvedere R; Pessolano E; Porta A; Tosco A; Parente L; Petrella F; Perretti M; Petrella A
Eur J Pharmacol; 2020 Feb; 869():172894. PubMed ID: 31883916
[TBL] [Abstract][Full Text] [Related]
27. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
Kwon M; MacLeod TJ; Zhang Y; Waisman DM
Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
[TBL] [Abstract][Full Text] [Related]
28. The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia.
Liu Y; Wang Z; Jiang M; Dai L; Zhang W; Wu D; Ruan C
Leuk Res; 2011 Jul; 35(7):879-84. PubMed ID: 21146216
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice.
Huang B; Deora AB; He KL; Chen K; Sui G; Jacovina AT; Almeida D; Hong P; Burgman P; Hajjar KA
Blood; 2011 Sep; 118(10):2918-29. PubMed ID: 21788340
[TBL] [Abstract][Full Text] [Related]
30. Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans.
Mao SS; Cooper CM; Wood T; Shafer JA; Gardell SJ
J Biol Chem; 1999 Dec; 274(49):35046-52. PubMed ID: 10574983
[TBL] [Abstract][Full Text] [Related]
31. The endothelial cell annexin A2 system and vascular fibrinolysis.
Dassah M; Deora AB; He K; Hajjar KA
Gen Physiol Biophys; 2009; 28 Spec No Focus(SPEC):F20-8. PubMed ID: 20093722
[TBL] [Abstract][Full Text] [Related]
32. The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.
Echart CL; Graziadio B; Somaini S; Ferro LI; Richardson PG; Fareed J; Iacobelli M
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):627-34. PubMed ID: 19809307
[TBL] [Abstract][Full Text] [Related]
33. Annexin II: a plasminogen-plasminogen activator co-receptor.
Kim J; Hajjar KA
Front Biosci; 2002 Feb; 7():d341-8. PubMed ID: 11815288
[TBL] [Abstract][Full Text] [Related]
34. Recombinant annexin II modulates impaired fibrinolytic activity in vitro and in rat carotid artery.
Ishii H; Yoshida M; Hiraoka M; Hajjar KA; Tanaka A; Yasukochi Y; Numano F
Circ Res; 2001 Dec; 89(12):1240-5. PubMed ID: 11739291
[TBL] [Abstract][Full Text] [Related]
35. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
[TBL] [Abstract][Full Text] [Related]
36. Role of annexin II tetramer in plasminogen activation.
Kang HM; Choi KS; Kassam G; Fitzpatrick SL; Kwon M; Waisman DM
Trends Cardiovasc Med; 1999; 9(3-4):92-102. PubMed ID: 10578524
[TBL] [Abstract][Full Text] [Related]
37. Annexin II and regulation of cell surface fibrinolysis.
Hajjar KA; Acharya SS
Ann N Y Acad Sci; 2000 May; 902():265-71. PubMed ID: 10865846
[TBL] [Abstract][Full Text] [Related]
38. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation.
Semov A; Moreno MJ; Onichtchenko A; Abulrob A; Ball M; Ekiel I; Pietrzynski G; Stanimirovic D; Alakhov V
J Biol Chem; 2005 May; 280(21):20833-41. PubMed ID: 15788416
[TBL] [Abstract][Full Text] [Related]
39. What drives "fibrinolysis"?
Medcalf RL
Hamostaseologie; 2015; 35(4):303-10. PubMed ID: 25564072
[TBL] [Abstract][Full Text] [Related]
40. Coupling of Integrin α5 to Annexin A2 by Flow Drives Endothelial Activation.
Zhang C; Zhou T; Chen Z; Yan M; Li B; Lv H; Wang C; Xiang S; Shi L; Zhu Y; Ai D
Circ Res; 2020 Sep; 127(8):1074-1090. PubMed ID: 32673515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
